Heart disease is the leading cause of death in the United States and to treat cardiovascular disease effectively, cardiologists must aggressively reduce both inflammation and cholesterol in their patients.
Heart disease can include weakening of the muscles of the heart, heart valves working improperly, or inflammation of the vascular system.
In this video Philip Nimoityn, MD, FACC, a clinical cardiologist, discusses the various ways we can monitor inflammation, and treat it with new tests and a new drug.
Watch our educational video to learn how you can avoid heart disease, and how you can manage risk if you have genetic or lifestyle predisposition to heart problems.
Our expert guest, Philip Nimoityn, MD, FACC is a clinical cardiologist at Cardiology Consultants of Philadelphia at Thomas Jefferson University. He is a diplomate of the American Board of Internal Medicine and Subspecialty Board of Cardiovascular Disease and is a Fellow of the American College of Cardiology. Dr. Nimoityn is a Clinical Assistant Professor of Medicine at Sidney Kimmel Medical College at Thomas Jefferson University and an Attending Physician at Thomas Jefferson University Hospital